Tandem Diabetes Care (TNDM) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Tandem Diabetes Care · Health Care · ref. ETF XLV · 54 calls · price $21.4
What the company does: Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
📈 Tandem Diabetes Care (TNDM) stock price
$21.4+81.5% over range
Aug 28, 25low $11.79 · high $28.26Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 14 analysts
📊 JPI status : Tandem Diabetes Care has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 TNDM price target & analyst consensus — price $21.40
The price target · all analysts combined (12 targets)
Highest target · 1 firm of 12$55+157.0%
Median target · of 12 targets$25.5+19.2%
Lowest target · 1 firm of 12$15.5-27.6%
Current price$21.4
Where these 12 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
975%
$25 ↔ $55
Below
325%
$15.50 ↔ $21
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 14 ratings (last 6 months)
Strong Buy00%
Buy750%
Hold750%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 TNDM price target all
All 54 calls, one by one, with our verdict on each firm.
→ See all 54 targets, analyst by analyst💡 The best analysts on TNDM most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in TNDM? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Tandem Diabetes Care? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on TNDM
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Craig-Hallum ↗ | 100% | +59.8% | 2 |
| UBS ↗ | 100% | +39.4% | 3 |
| Baird ↗ | 67% | +57.8% | 3 |
| RBC Capital ↗ | 67% | +16.3% | 3 |
| Lake Street | 50% | +85.5% | 2 |
| B of A Securities ↗ | 50% | +30.1% | 2 |
| Jefferies ↗ | 50% | +9.4% | 2 |
| Barclays ↗ | 50% | -3.5% | 8 |
| Raymond James ↗ | 50% | -14.3% | 12 |
| Canaccord Genuity ↗ | 40% | -0.8% | 5 |
See the other 7 firms
| Wedbush ↗ | 0% | -70.5% | 2 |
| Stifel ↗ | 0% | -45.4% | 7 |
| Deutsche Bank ↗ | 0% | -45.3% | 5 |
| Cowen & Co. | 0% | -15.0% | 2 |
| Wells Fargo ↗ | 25% | -36.4% | 8 |
| Piper Sandler ↗ | 30% | +31.5% | 10 |
| Citigroup ↗ | 38% | -11.6% | 8 |
📊 What $1,000 invested in Tandem Diabetes Care would be worth › open the full page
In short — $1,000 invested in Tandem Diabetes Care 10 years ago would be worth $132 today, i.e. -18%/yr on average. Best year: 2018 (+1509%), worst: 2017 (-89%). Price performance, excluding dividends.
If I'd invested $1,000 in Tandem Diabetes Care
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $431 | -57% |
| 3 years ago | $346 | -65% |
| 5 years ago | $162 | -84% |
Return by year (Tandem Diabetes Care)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -29% | $707 (-29%) |
| 2025 | -39% | $431 (-57%) |
| 2024 | +22% | $525 (-47%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Tandem Diabetes Care
Loading news…
📋 All analyst calls on TNDM
Filtered on — · ✕ show all
William Blair ↗
Aug 21, 26
▲ Outperform
🎯 on TNDM : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Aug 21, 27
matures : Aug 21, 27
■ Neutral neutral · not a buy · 🎯$21
Price at call : $22.81 — gap to target -8%
Today : $21.4 — gap to target -2%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
RBC Capital ↗
Aug 7, 26
▲ Outperform · 🎯$26
Price at call : $22.81 — upside +14%
Today : $21.4 — upside +21%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Neutral neutral · not a buy · 🎯$20
Price at call : $16.29 — gap to target +23%
Today : $21.4 — gap to target -7%
🎯 on TNDM : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Deutsche Bank ↗
Jun 23, 26
■ Hold neutral · not a buy · 🎯$15.5
Price at call : $14.41 — gap to target +8%
Today : $21.4 — gap to target -28%
🎯 on TNDM : no call matured yet · 📊 on Health : 32.7% · -7.6% (55 calls)
in progress (365j)
matures : Jun 23, 27
matures : Jun 23, 27
Wells Fargo ↗
Jun 1, 26
▲ Overweight · 🎯$27
Price at call : $18.6 — upside +45%
Today : $21.4 — upside +26%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
■ Neutral neutral · not a buy · 🎯$17
Price at call : $17.2 — gap to target -1%
Today : $21.4 — gap to target -21%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
B of A Securities ↗
May 18, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $13.86 — gap to target +80%
Today : $21.4 — gap to target +17%
🎯 on TNDM : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
See the other 46 calls, newest to oldest
■ Hold neutral · not a buy
🎯 on TNDM : no call matured yet · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
Truist Securities ↗
May 11, 26
▲ Buy · 🎯$31
Price at call : $14.69 — upside +111%
Today : $21.4 — upside +45%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
▲ Overweight · 🎯$55
Price at call : $14.69 — upside +274%
Today : $21.4 — upside +157%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
▲ Buy · 🎯$28
Price at call : $20.03 — upside +40%
Today : $21.4 — upside +31%
🎯 on TNDM : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
Goldman Sachs ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $19.18 — gap to target +30%
Today : $21.4 — gap to target +17%
🎯 on TNDM : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
Truist Securities ↗
Mar 19, 26
▲ Buy · 🎯$35
Price at call : $24.63 — upside +42%
Today : $21.4 — upside +64%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
Piper Sandler ↗
Mar 17, 26
▲ Overweight · 🎯$33
Price at call : $23.91 — upside +38%
Today : $21.4 — upside +54%
🎯 on TNDM : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
Morgan Stanley ↗
Mar 2, 26
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $23.74 — gap to target +5%
Today : $21.4 — gap to target +17%
🎯 on TNDM : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Lake Street
Feb 23, 26
▲ Buy · 🎯$50
Price at call : $26.9 — upside +86%
Today : $21.4 — upside +134%
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 61.5% · +24.8% (26 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
Truist Securities ↗
Feb 23, 26
■ Hold neutral · not a buy · 🎯$27
Price at call : $28.26 — gap to target -4%
Today : $21.4 — gap to target +26%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $28.26 — gap to target -22%
Today : $21.4 — gap to target +3%
🎯 on TNDM : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $28.26 — gap to target -22%
Today : $21.4 — gap to target +3%
🎯 on TNDM : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
■ Hold neutral · not a buy · 🎯$22
Price at call : $24.57 — gap to target -10%
Today : $21.4 — gap to target +3%
🎯 on TNDM : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
B of A Securities ↗
Feb 20, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $24.57 — gap to target +22%
Today : $21.4 — gap to target +40%
🎯 on TNDM : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Piper Sandler ↗
Feb 20, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $24.57 — gap to target -15%
Today : $21.4 — gap to target -2%
🎯 on TNDM : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
■ Hold neutral · not a buy · 🎯$20
Price at call : $18.99 — gap to target +5%
Today : $21.4 — gap to target -7%
🎯 on TNDM : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
■ Market Perform neutral · not a buy · 🎯$25
Price at call : $21.35 — gap to target +17%
Today : $21.4 — gap to target +17%
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 25% · -33.8% (4 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
Truist Securities ↗
Dec 18, 25
■ Hold neutral · not a buy · 🎯$24
Price at call : $22.07 — gap to target +9%
Today : $21.4 — gap to target +12%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
Canaccord Genuity ↗
Dec 17, 25
▲ Buy · 🎯$35
Price at call : $21.8 — upside +61%
Today : $21.4 — upside +64%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $22.42 — gap to target -6%
Today : $21.4 — gap to target -2%
🎯 on TNDM : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Outperform · 🎯$30
Price at call : $22.6 — upside +33%
Today : $21.4 — upside +40%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
■ Neutral neutral · not a buy · 🎯$22
Price at call : $21.39 — gap to target +3%
Today : $21.4 — gap to target +3%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
Morgan Stanley ↗
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $19.93 — gap to target +15%
Today : $21.4 — gap to target +7%
🎯 on TNDM : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
▲ Overweight · 🎯$55
Price at call : $17.52 — upside +214%
Today : $21.4 — upside +157%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Morgan Stanley ↗
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$17
Price at call : $17.52 — gap to target -3%
Today : $21.4 — gap to target -21%
🎯 on TNDM : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Truist Securities ↗
Nov 10, 25
■ Hold neutral · not a buy · 🎯$17
Price at call : $17.52 — gap to target -3%
Today : $21.4 — gap to target -21%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Wells Fargo ↗
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $16.37 — gap to target -14%
Today : $21.4 — gap to target -35%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Truist Securities ↗
Oct 15, 25
■ Hold neutral · not a buy · 🎯$16
Price at call : $15.29 — gap to target +5%
Today : $21.4 — gap to target -25%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
■ Neutral neutral · not a buy · 🎯$15
Price at call : $15.34 — gap to target -2%
Today : $21.4 — gap to target -30%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Canaccord Genuity ↗
Sep 29, 25
▲ Buy · 🎯$24
Price at call : $12.14 — upside +98%
Today : $21.4 — upside +12%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Sep 29, 26
matures : Sep 29, 26
Oppenheimer ↗
Sep 8, 25
▲ Outperform · 🎯$22
Price at call : $12.56 — upside +75%
Today : $21.4 — upside +3%
🎯 on TNDM : no call matured yet · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Sep 8, 26
matures : Sep 8, 26
■ Neutral neutral · not a buy · 🎯$11
Price at call : $11.93 — gap to target -8%
Today : $21.4 — gap to target -49%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 21, 26
matures : Aug 21, 26
■ Neutral neutral · not a buy · 🎯$10.35
Price at call : $11.1 — gap to target -7%
Today : $21.4 — gap to target -52%
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 12, 26
matures : Aug 12, 26
Lake Street
Aug 11, 25
■ Hold neutral · not a buy · 🎯$12
Price at call : $11.1 — gap to target +8%
Today : $21.4 — gap to target -44%
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 61.5% · +24.8% (26 calls)
in progress (365j)
matures : Aug 11, 26
matures : Aug 11, 26
▲ Overweight · 🎯$51
Price at call : $10.11 — upside +404%
Today : $21.4 — upside +138%
Expected +404% · Actual +126% · Reason (≥ +15%) : ✓ Yes
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
+125.5%
stock +126% · XLV +29%
matured Aug 8, 26
Canaccord Genuity ↗
Aug 8, 25
▲ Buy · 🎯$24
Price at call : $11.23 — upside +114%
Today : $21.4 — upside +12%
Expected +114% · Actual +103% · Reason (≥ +15%) : ✓ Yes
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
+103.1%
stock +103% · XLV +29%
matured Aug 8, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $11.23 — gap to target +51%
Today : $21.4 — gap to target -21%
🎯 on TNDM : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
RBC Capital ↗
Aug 7, 25
▲ Outperform · 🎯$25
Price at call : $11.23 — upside +123%
Today : $21.4 — upside +17%
Expected +123% · Actual +103% · Reason (≥ +15%) : ✓ Yes
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 30.7% · -10.7% (166 calls)
+103.1%
stock +103% · XLV +29%
matured Aug 7, 26
Wells Fargo ↗
Aug 7, 25
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $11.23 — gap to target +16%
Today : $21.4 — gap to target -39%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
Piper Sandler ↗
Aug 7, 25
■ Neutral neutral · not a buy · 🎯$14
Price at call : $11.52 — gap to target +22%
Today : $21.4 — gap to target -35%
🎯 on TNDM : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
▼ Sell · 🎯$14
Price at call : $15.85 — upside -12%
Today : $21.4 — upside -35%
Expected -12% · Actual -3% · Reason (≤ −15%) : ✗ No
🎯 on TNDM : 100% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
+3.0%
stock -3% · XLV +20%
matured Jul 9, 26
Truist Securities ↗
Jun 16, 25
■ Hold neutral · not a buy · 🎯$24
Price at call : $20.07 — gap to target +20%
Today : $21.4 — gap to target +12%
🎯 on TNDM : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Jun 16, 26
matures : Jun 16, 26
▲ Outperform · 🎯$42
Price at call : $34.24 — upside +23%
Today : $21.4 — upside +96%
Expected +23% · Actual -61% · Reason (≥ +15%) : ✗ No
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 25% · -33.8% (4 calls)
-61.1%
stock -61% · XLV -1%
matured Nov 6, 25
Lake Street
May 22, 24
▲ Buy · 🎯$75
Price at call : $49.68 — upside +51%
Today : $21.4 — upside +250%
Expected +51% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 61.5% · +24.8% (26 calls)
-58.3%
stock -58% · XLV -10%
matured May 22, 25
Leerink Partners ↗
Apr 25, 24
▲ Outperform · 🎯$45
Price at call : $35.56 — upside +27%
Today : $21.4 — upside +110%
Expected +27% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 50% · -5.3% (10 calls)
-49.2%
stock -49% · XLV -1%
matured Apr 25, 25
Leerink Partners ↗
Oct 16, 23
■ Market Perform neutral · not a buy · 🎯$21
Price at call : $18.63 — gap to target +13%
Today : $21.4 — gap to target -2%
🎯 on TNDM : 0% (1 call matured) · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Oct 15, 24
matures : Oct 15, 24
Frequently asked questions
Should I buy Tandem Diabetes Care stock?
This isn't buy advice. For Tandem Diabetes Care, the analyst consensus is "Buy", with an average price target of $25.50 (+19% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Tandem Diabetes Care). We show the numbers — you decide.
Is it too late to buy Tandem Diabetes Care? How high can it go?
The most bullish analyst target on Tandem Diabetes Care is $55.00 (+157% above today's price); the average is $25.50. That's the upside they see. Check how reliable those analysts have actually been on Tandem Diabetes Care on our site before trusting it.
Is Tandem Diabetes Care still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Tandem Diabetes Care, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Tandem Diabetes Care? The case for and against
The arguments for and against, one by one, from the numbers: why invest in TNDM (and why hesitate).
What has Tandem Diabetes Care's past performance been?
Historical returns and a "how much if I had invested" calculator: TNDM performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX